Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals, people familiar with the matter said, as it seeks to expand its global footprint.
Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals, according to people familiar with the matter.
What happened
Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals, according to people familiar with the matter.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near Italy
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Poet Technologies stock plunges nearly 50% after Marvell deal sours — its largest single-day decline on record.
Poet Technologies' stock dropped nearly 50%, a record decline, after its deal with Marvell Technology soured.
Real Brokerage to acquire RE/MAX in $880 million deal.
Real Brokerage is to acquire RE/MAX in an $880 million deal.
Justin Sun sues Trump World Liberty Financial over blocked $1B token sale.
Cryptocurrency billionaire Justin Sun is suing World Liberty Financial, a crypto venture co-founded by President Donald Trump and his sons, alleging the company illegally blocked him from selling digital tokens worth up to $1 billion.
U.S. refiners are expected to post sharply higher first-quarter profits as war-driven fuel margin increases boost earnings, analysts say.
U.S. refiners are expected to report higher first-quarter profits as war lifts fuel margins.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.